Goodwill Pharma Plc. has significantly expanded its production and warehouse capacity
Goodwill Pharma Plc. has expanded its warehouse capacity, built a research, development and innovation laboratory, a new central office, and a pharmaceutical manufacturing plant in Szeged. The investment, worth almost 5 billion forints, was handed over on Thursday.
Ferenc Jójárt, the CEO of the Szeged company, said at the ceremony that Goodwill Pharma is proof of how a multinational pharmaceutical company can be built from a rural town in Hungary.
Between June 2022 and the end of November last year, developments were implemented at three locations with 1.767 billion forints of conditionally non-refundable EU and domestic support within the framework of the Hungarian Multi Program.
The company has developed a logistics center sufficient to store 4-5 thousand pallets of medicines. It has built a manufacturing plant that meets pharmaceutical industry standards, to which the first machines have already arrived, so the first Szeged-manufactured medicines may be produced at the company by the end of the year or early next year.
The company has established a new pharmaceutical laboratory to expand its research and development activities, and has also developed a new office building in the city center of Szeged – the CEO explained the details of the developments.
Related news
OMV is starting to distribute medicines at nearly 100 filling stations in Hungary
Since spring, over-the-counter medicines have been available at 99 OMV…
Read more >Related news
foodora: Condoms are being ordered as early as 7am on Valentine’s Day
Florists are busy, but many people also order chocolate and…
Read more >The growth of Hungarian e-commerce is now driven by imports
In 2024, the entire Hungarian e-commerce market, based on PwC’s…
Read more >Chamber of Commerce’s little smart guy helps producers involved in farm transfers
The National Chamber of Agriculture has prepared a guide for…
Read more >